The contribution of ExpreS2ion is cited in this issue of the journal “Vaccine”, which reviews the status on Malaria vaccine development.

Edited by Robert W. Sauerwein and Thomas L. Richie
Access the journal issue here:
Articles citing the use of ExpreS2: Recent advances in recombinant protein-based malaria vaccines. Draper et al.